Ronilda D’Cunha

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Efficacy and Safety of <scp>ABBV</scp>‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with <scp>Moderate‐to‐Severe</scp> Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, <scp>Double‐Blind</scp>, <scp>Active‐Controlled Proof‐of‐Concept</scp> Phase <scp>IIa</scp> Trial

Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich et al. · Arthritis & Rheumatology · 2022 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp‐ and BCRP‐mediated efflux

Ronilda D’Cunha, SoHyun Bae, Daryl J. Murry et al. · Biopharmaceutics & Drug Disposition · 2016 · 50 citations

Medicine, Oncology, Pharmacology +17

Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation

Ronilda D’Cunha, Thanh Bach, Beth Ann Young et al. · Antimicrobial Agents and Chemotherapy · 2018 · 39 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases

Michael Mcpherson, Adrian D. Hobson, Axel Hernández et al. · Science Translational Medicine · 2024 · 27 citations

Pharmacy, Immunology, Pharmacology +17